Human papillomavirus (HPV) is the second most common cancer-causing virus, accounting for 690,000 cervical and other cancers each year worldwide. While the immune system usually clears HPV infections, those that persist can lead to cancer, and a new finding suggests that certain women may have a genetic susceptibility for persistent or frequent HPV infections. These genetic variants could raise a woman's risk of getting cervical cancer from a high-risk HPV infection ..read more

Cancer resists treatment in a multitude of ways, but a new algorithm developed can decode them all simultaneously ..read more

The most effective way to prevent cervical cancer is to give HPV vaccines to both boys and girls, reports a collaborative study. Beside personal immunity, such use of the vaccine also induces a herd immunity that will help to eradicate the carcinogenic virus types more quickly ..read more

A course of treatment with existing drugs prior to chemo-radiation led to a 35% reduction in the risk of death or return of cancer ..read more

Researchers found that across the U.S., anal cancer incidence and mortality rates increased 1.5-fold in men and women over 50 years old. However, the most prominent increase -- more than two-fold -- occurred among people over 50 years of age living in the Midwestern and Southeastern states ..read more

Investigators analyzed longitudinal samples of cervical and serum biomarker levels for immune activation, before and after subjects acquired HSV-2. They found that altered levels of specific biomarkers in the mucosa and serum were associated with HSV-2 acquisition only, while others overlapped with biomarkers and combinations predictive of HIV-1 acquisition ..read more

A major clinical trial looking at surgery for women at risk of miscarriage and stillbirth have found that a type of wire commonly used reduces risk of infection ..read more

Researchers have shown that treating precancerous anal growths called high-grade squamous intraepithelial lesions (HSILs) in persons living with HIV significantly decreased the progression to anal cancer ..read more

The most effective intervention to prevent preterm birth is the administration of a natural hormone, progesterone, in patients at risk for premature delivery. Two categories of patients have been eligible for this treatment: those with a short cervix and those with a previous preterm birth. But new research indicates that progesterone is not effective in reducing the rate of preterm birth in women with a prior history of preterm birth ..read more

New findings show the number of women in the United States who reported having a recent (in the past year) breast cancer or cervical cancer screening dropped by 2.13 million (6%) and 4.47 million (11%) respectively in 2020 compared to 2018. The study is the first of its kind to evaluate the impact of the COVID-19 pandemic on cancer screenings nationally using population-based data ..read more